Clinical Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rubbia-Brandt, L.
Right arrow Articles by Pepper, M. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rubbia-Brandt, L.
Right arrow Articles by Pepper, M. S.
Clinical Cancer Research Vol. 10, 6919-6928, October 15, 2004
© 2004 American Association for Cancer Research


Molecular Oncology, Markers, Clinical Correlates

Lymphatic Vessel Density and Vascular Endothelial Growth Factor-C Expression Correlate with Malignant Behavior in Human Pancreatic Endocrine Tumors

Laura Rubbia-Brandt1, Benoit Terris5, Emile Giostra2, Bertrand Dousset6, Philippe Morel3 and Michael S. Pepper4

Services of 1 Clinical Pathology, 2 Gastroenterology and Hepatology, and 3 Digestive Surgery, Geneva University Hospital, Geneva, Switzerland; 4 Department of Morphology, University Medical Center, Geneva, Switzerland; and 5 Services d’Anatomie Pathologique and 6 Surgery, Hôpital Cochin, Paris, France

Metastatic dissemination of tumor cells to regional lymph nodes is a common early feature of many human cancers including pancreatic adenocarcinoma. In contrast, lymph node metastasis is more variably observed in pancreatic endocrine tumors. The objective of this study was to assess the lymphatic system of human pancreatic endocrine tumors and correlate this to clinical behavior. Immunohistochemistry was performed using antibodies to two recently identified markers of lymphatic endothelium, namely, LYVE-1 and podoplanin, and to the lymphangiogenic factor vascular endothelial growth factor (VEGF)-C. As has been reported previously, we observed that in the normal pancreas, islets of Langerhans are devoid of intra-islet lymphatics, but that lymphatics are present in connective tissue in association with ducts and blood vessels. We found that both benign and malignant pancreatic endocrine tumors contain intratumoral lymphatic vessels. Lymphatic vessel density was related to the size of the tumor in benign tumors and to the presence of liver metastasis but not to lymph node metastasis in malignant tumors. VEGF-C was expressed in tumor cells: 4 of 19 (21%) benign tumors were positive, whereas 6 of 9 (67%) borderline tumors and 9 of 11 (82%) carcinomas were positive. These findings strongly suggest that lymphangiogenesis occurs in pancreatic endocrine tumors and that lymphatic invasion and the development of metastases are associated with VEGF-C expression.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
L. A. Johnson, R. Prevo, S. Clasper, and D. G. Jackson
Inflammation-induced Uptake and Degradation of the Lymphatic Endothelial Hyaluronan Receptor LYVE-1
J. Biol. Chem., November 16, 2007; 282(46): 33671 - 33680.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
P. A. Vagefi, O. Razo, V. Deshpande, D. J. McGrath, G. Y. Lauwers, S. P. Thayer, A. L. Warshaw, and C. Fernandez-del Castillo
Evolving Patterns in the Detection and Outcomes of Pancreatic Neuroendocrine Neoplasms: The Massachusetts General Hospital Experience From 1977 to 2005
Arch Surg, April 1, 2007; 142(4): 347 - 354.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
L. A. Johnson, S. Clasper, A. P. Holt, P. F. Lalor, D. Baban, and D. G. Jackson
An inflammation-induced mechanism for leukocyte transmigration across lymphatic vessel endothelium
J. Exp. Med., November 27, 2006; 203(12): 2763 - 2777.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
R. Shayan, M. G. Achen, and S. A. Stacker
Lymphatic vessels in cancer metastasis: bridging the gaps
Carcinogenesis, September 1, 2006; 27(9): 1729 - 1738.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
F. Renyi-Vamos, J. Tovari, J. Fillinger, J. Timar, S. Paku, I. Kenessey, G. Ostoros, L. Agocs, I. Soltesz, and B. Dome
Lymphangiogenesis Correlates with Lymph Node Metastasis, Prognosis, and Angiogenic Phenotype in Human Non-Small Cell Lung Cancer
Clin. Cancer Res., October 15, 2005; 11(20): 7344 - 7353.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. He, I. Rajantie, K. Pajusola, M. Jeltsch, T. Holopainen, S. Yla-Herttuala, T. Harding, K. Jooss, T. Takahashi, and K. Alitalo
Vascular Endothelial Cell Growth Factor Receptor 3-Mediated Activation of Lymphatic Endothelium Is Crucial for Tumor Cell Entry and Spread via Lymphatic Vessels
Cancer Res., June 1, 2005; 65(11): 4739 - 4746.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.